These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 19028723

  • 1. Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy.
    Akki A, Seymour AM.
    Cardiovasc Res; 2009 Feb 15; 81(3):610-7. PubMed ID: 19028723
    [Abstract] [Full Text] [Related]

  • 2. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
    Doenst T, Pytel G, Schrepper A, Amorim P, Färber G, Shingu Y, Mohr FW, Schwarzer M.
    Cardiovasc Res; 2010 Jun 01; 86(3):461-70. PubMed ID: 20035032
    [Abstract] [Full Text] [Related]

  • 3. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
    Aasum E, Cooper M, Severson DL, Larsen TS.
    Can J Physiol Pharmacol; 2005 Feb 01; 83(2):183-90. PubMed ID: 15791292
    [Abstract] [Full Text] [Related]

  • 4. Regression of cardiac hypertrophy normalizes glucose metabolism and left ventricular function during reperfusion.
    Wambolt RB, Henning SL, English DR, Bondy GP, Allard MF.
    J Mol Cell Cardiol; 1997 Mar 01; 29(3):939-48. PubMed ID: 9152855
    [Abstract] [Full Text] [Related]

  • 5. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat.
    Christe ME, Rodgers RL.
    J Mol Cell Cardiol; 1994 Oct 01; 26(10):1371-5. PubMed ID: 7869397
    [Abstract] [Full Text] [Related]

  • 6. Metabolic remodeling in the aging heart.
    Sample J, Cleland JG, Seymour AM.
    J Mol Cell Cardiol; 2006 Jan 01; 40(1):56-63. PubMed ID: 16324710
    [Abstract] [Full Text] [Related]

  • 7. Dietary fat supply to failing hearts determines dynamic lipid signaling for nuclear receptor activation and oxidation of stored triglyceride.
    Lahey R, Wang X, Carley AN, Lewandowski ED.
    Circulation; 2014 Nov 11; 130(20):1790-9. PubMed ID: 25266948
    [Abstract] [Full Text] [Related]

  • 8. Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats.
    Golfman LS, Wilson CR, Sharma S, Burgmaier M, Young ME, Guthrie PH, Van Arsdall M, Adrogue JV, Brown KK, Taegtmeyer H.
    Am J Physiol Endocrinol Metab; 2005 Aug 11; 289(2):E328-36. PubMed ID: 15797988
    [Abstract] [Full Text] [Related]

  • 9. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization.
    Luptak I, Balschi JA, Xing Y, Leone TC, Kelly DP, Tian R.
    Circulation; 2005 Oct 11; 112(15):2339-46. PubMed ID: 16203912
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
    Pellieux C, Aasum E, Larsen TS, Montessuit C, Papageorgiou I, Pedrazzini T, Lerch R.
    J Mol Cell Cardiol; 2006 Sep 11; 41(3):459-66. PubMed ID: 16859699
    [Abstract] [Full Text] [Related]

  • 11. Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure.
    Kato T, Niizuma S, Inuzuka Y, Kawashima T, Okuda J, Tamaki Y, Iwanaga Y, Narazaki M, Matsuda T, Soga T, Kita T, Kimura T, Shioi T.
    Circ Heart Fail; 2010 May 11; 3(3):420-30. PubMed ID: 20176713
    [Abstract] [Full Text] [Related]

  • 12. Metabolic profiling of hearts exposed to sevoflurane and propofol reveals distinct regulation of fatty acid and glucose oxidation: CD36 and pyruvate dehydrogenase as key regulators in anesthetic-induced fuel shift.
    Wang L, Ko KW, Lucchinetti E, Zhang L, Troxler H, Hersberger M, Omar MA, Posse de Chaves EI, Lopaschuk GD, Clanachan AS, Zaugg M.
    Anesthesiology; 2010 Sep 11; 113(3):541-51. PubMed ID: 20683255
    [Abstract] [Full Text] [Related]

  • 13. Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway.
    Meng RS, Pei ZH, Yin R, Zhang CX, Chen BL, Zhang Y, Liu D, Xu AL, Dong YG.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):63-70. PubMed ID: 19699196
    [Abstract] [Full Text] [Related]

  • 14. PPARdelta activation normalizes cardiac substrate metabolism and reduces right ventricular hypertrophy in congestive heart failure.
    Jucker BM, Doe CP, Schnackenberg CG, Olzinski AR, Maniscalco K, Williams C, Hu TC, Lenhard SC, Costell M, Bernard R, Sarov-Blat L, Steplewski K, Willette RN.
    J Cardiovasc Pharmacol; 2007 Jul 12; 50(1):25-34. PubMed ID: 17666912
    [Abstract] [Full Text] [Related]

  • 15. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
    Aasum E, Khalid AM, Gudbrandsen OA, How OJ, Berge RK, Larsen TS.
    J Mol Cell Cardiol; 2008 Jan 12; 44(1):201-9. PubMed ID: 17931655
    [Abstract] [Full Text] [Related]

  • 16. Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts.
    Sorokina N, O'Donnell JM, McKinney RD, Pound KM, Woldegiorgis G, LaNoue KF, Ballal K, Taegtmeyer H, Buttrick PM, Lewandowski ED.
    Circulation; 2007 Apr 17; 115(15):2033-41. PubMed ID: 17404155
    [Abstract] [Full Text] [Related]

  • 17. Cardiac fatty acid metabolism is preserved in the compensated hypertrophic rat heart.
    Degens H, de Brouwer KF, Gilde AJ, Lindhout M, Willemsen PH, Janssen BJ, van der Vusse GJ, van Bilsen M.
    Basic Res Cardiol; 2006 Jan 17; 101(1):17-26. PubMed ID: 16136293
    [Abstract] [Full Text] [Related]

  • 18. Western diet increases cardiac ceramide content in healthy and hypertrophied hearts.
    Butler TJ, Ashford D, Seymour AM.
    Nutr Metab Cardiovasc Dis; 2017 Nov 17; 27(11):991-998. PubMed ID: 29070436
    [Abstract] [Full Text] [Related]

  • 19. Fatty acid metabolism assessed by 125I-iodophenyl 9-methylpentadecanoic acid (9MPA) and expression of fatty acid utilization enzymes in volume-overloaded hearts.
    Miyamoto T, Takeishi Y, Tazawa S, Inoue M, Aoyama T, Takahashi H, Arimoto T, Shishido T, Tomoike H, Kubota I.
    Eur J Clin Invest; 2004 Mar 17; 34(3):176-81. PubMed ID: 15025675
    [Abstract] [Full Text] [Related]

  • 20. Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation.
    Akki A, Smith K, Seymour AM.
    Mol Cell Biochem; 2008 Apr 17; 311(1-2):215-24. PubMed ID: 18278440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.